Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.49 |
| ▸ | RORA | P35398 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.46 |
| ▸ | RORB | Q92753 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | MAT2A | P31153 | 1/20 | 0.39 |
| ▸ | PDE2A | O00408 | 1/20 | 0.38 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21304002 | 0.90 | NPY5R (0.59) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL20097037 | 0.85 | KIF11 (0.51) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL26996629 | 0.85 | MEN1 (0.50) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL21311147 | 0.85 | KIF11 (0.57) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL21311348 | 0.83 | ALDH1A1 (0.46) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL21304004 | 0.81 | ALDH1A1 (0.55) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL20096980 | 0.81 | KIF11 (0.46) | KIF11NPY5RRORARORCRORB | |
| SCHEMBL150044 | 0.78 | BCHE (0.59) | NPY5RKMT2AMEN1ALDH1A1BCHE | |
| SCHEMBL29780042 | 0.78 | BCHE (0.59) | NPY5RKMT2AMEN1ALDH1A1BCHE | |
| SCHEMBL20097051 | 0.78 | ATM (0.50) | KIF11NPY5RRORARORCRORB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11638390-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2023-04-25 | — | — | US | disclosed |
| US-10644249-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-20200119287-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2020-04-16 | — | — | US | disclosed |
| US-20190267554-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | Kyulux North America, Inc. | 2019-08-29 | — | — | US | disclosed |
| US-20190262371-A1 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-08-29 | — | — | US | disclosed |
| WO-2018075947-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RNA VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200119287-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, CLTB, CYBA | KIF11 3101/4885NPY5R 4097/4885RORA 900/4885 |
| US-10644249-B2 | Composition of matter for use in organic light-emitting diodes | NDUFV3, SLCO1B3, CRY2 | KIF11 3203/4885NPY5R 2745/4885RORA 697/4885 |
| US-20190262371-A1 | METHODS AND COMPOSITION FOR THE TREATMENT OF RNA VIRAL INFECTIONS | POLRMT, EIF2AK2, NSUN3 | KIF11 3214/4885NPY5R 4867/4885RORA 2229/4885 |
| US-20190267554-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | NDUFV3, SLCO1B3, CRY2 | KIF11 3203/4885NPY5R 2745/4885RORA 697/4885 |
| US-11638390-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, CLTB, CYBA | KIF11 3101/4885NPY5R 4097/4885RORA 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.